Comparing different triple-drug combinations.
Replacing the PI with abacavir in a triple-drug regimen resulted in continued plasma viral-load suppression and improvements in lipid abnormalities. In another study, PI-containing triple-drug combinations were more likely to reduce viral burden in lymphoid tissue than were PI-sparing regimens.